Literature DB >> 30136024

Fatigue predicts impaired social adjustment in survivors of allogeneic hematopoietic cell transplantation (HCT).

Jumin Park1, Leslie Wehrlen1, Sandra A Mitchell2, Li Yang1, Margaret F Bevans3.   

Abstract

PURPOSE: The aim of this study is to examine social adjustment to illness and to identify factors related to social adjustment in allogeneic hematopoietic cell transplantation (HCT) survivors.
METHODS: Cross-sectional data were drawn from a longitudinal study of patients ≥ 3 years after their first HCT. The five subscales of the Psychosocial Adjustment to Illness Scale (PAIS) that reflect social adjustment, specifically vocational environment (VE); domestic environment (DE); sexual relationships (SEX); extended family relationships (ER); and social environment (SE) were examined in this analysis. Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) measured cancer-related fatigue.
RESULTS: Subjects (N = 171) were a median of 5.19 years from HCT (range 3-16). The most impaired dimension of social adjustment was ER with 38% of participants reaching clinically relevant (score ≥ 62) levels of social maladjustment. Unmarried and unemployed participants had lower levels of social adjustment in VE (p < .001 and p < .001, respectively) and DE (p = .004 and p = .006, respectively). Survivors with some college had poorer SEX adjustment than those with less or more education (p < .005). Hispanics reported lower adjustment with respect to ER adjustment (p = .002). Participants with higher fatigue had poorer adjustment in all five dimensions (p < .001).
CONCLUSIONS: Although the majority of survivors are well adjusted, subgroups may experience significant poor social adjustment. Specifically, survivors with fatigue are at risk to experience lower levels of social adjustment. Development of effective rehabilitation strategies to improve affected areas of social health is warranted, and all HCT survivors should be screened periodically for social maladjustment and provided with resources and referrals.

Entities:  

Keywords:  Cancer survivors; Fatigue; Hematopoietic stem cell transplantation; Social adjustment

Mesh:

Year:  2018        PMID: 30136024      PMCID: PMC6953476          DOI: 10.1007/s00520-018-4411-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  42 in total

Review 1.  Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation.

Authors:  Maxim Norkin; Jack W Hsu; John R Wingard
Journal:  Semin Hematol       Date:  2012-01       Impact factor: 3.851

2.  Quality of life and social integration after allogeneic hematopoietic SCT.

Authors:  S Bieri; E Roosnek; C Helg; F Verholen; D Robert; B Chapuis; J Passweg; R Miralbell; Y Chalandon
Journal:  Bone Marrow Transplant       Date:  2008-08-18       Impact factor: 5.483

Review 3.  Cost and quality issues in establishing hematopoietic cell transplant program in developing countries.

Authors:  Shahrukh K Hashmi; Alok Srivastava; Walid Rasheed; Salman Adil; Tong Wu; Madan Jagasia; Amr Nassar; William Y K Hwang; Amir Ali Hamidieh; Hildegard T Greinix; Marcelo C Pasquini; Jane F Apperley; Mahmoud Aljurf
Journal:  Hematol Oncol Stem Cell Ther       Date:  2017-07-14

4.  Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

Authors:  Christine N Duncan; Navneet S Majhail; Ruta Brazauskas; Zhiwei Wang; Jean-Yves Cahn; Haydar A Frangoul; Robert J Hayashi; Jack W Hsu; Rammurti T Kamble; Kimberly A Kasow; Nandita Khera; Hillard M Lazarus; Alison W Loren; David I Marks; Richard T Maziarz; Paulette Mehta; Kasiani C Myers; Maxim Norkin; Joseph A Pidala; David L Porter; Vijay Reddy; Wael Saber; Bipin N Savani; Harry C Schouten; Amir Steinberg; Donna A Wall; Anne B Warwick; William A Wood; Lolie C Yu; David A Jacobsohn; Mohamed L Sorror
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-12       Impact factor: 5.742

5.  Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.

Authors:  Margaret F Bevans; Sandra A Mitchell; John A Barrett; Michael R Bishop; Richard Childs; Daniel Fowler; Michael Krumlauf; Patricia Prince; Nonniekaye Shelburne; Leslie Wehrlen; Li Yang
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-17       Impact factor: 5.742

6.  Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.

Authors:  Eileen Hacker Danaher; Carol Ferrans; Ellen Verlen; Farhad Ravandi; Koen van Besien; Julie Gelms; Natalie Dieterle
Journal:  Oncol Nurs Forum       Date:  2006-05-03       Impact factor: 2.172

7.  Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT.

Authors:  P Esser; K Kuba; A Mehnert; A Schwinn; L Schirmer; F Schulz-Kindermann; M Kruse; U Koch; A R Zander; N Kröger; G Schilling; H Götze; A Scherwath
Journal:  Bone Marrow Transplant       Date:  2017-01-23       Impact factor: 5.483

Review 8.  Delivering care to long-term adult survivors of hematopoietic cell transplantation.

Authors:  Karen L Syrjala; Paul J Martin; Stephanie J Lee
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

Review 9.  Stem cell transplantation: supportive care and long-term complications.

Authors:  John R Wingard; Georgia B Vogelsang; H Joachim Deeg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

10.  Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.

Authors:  A Im; S A Mitchell; S M Steinberg; L Curtis; A Berger; K Baird; Z Kuzmina; G Joe; L E Comis; M Juckett; D Avila; J Baruffaldi; L Masuch; F Pirsl; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2016-02-01       Impact factor: 5.483

View more
  5 in total

1.  Psychosocial and financial issues after hematopoietic cell transplantation.

Authors:  David Buchbinder; Nandita Khera
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients.

Authors:  Jennifer M Knight; Mallory R Taylor; Kelly E Rentscher; Elisabeth C Henley; Hannah A Uttley; Ashley M Nelson; Lucie M Turcotte; Natalie S McAndrew; Hermioni L Amonoo; Lathika Mohanraj; Debra Lynch Kelly; Erin S Costanzo
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

3.  Harnessing digital health to objectively assess cancer-related fatigue: The impact of fatigue on mobility performance.

Authors:  Yvonne H Sada; Olia Poursina; He Zhou; Biruh T Workeneh; Sandhya V Maddali; Bijan Najafi
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

4.  Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.

Authors:  Sencer Goklemez; Leorey N Saligan; Filip Pirsl; Noa G Holtzman; Alen Ostojic; Seth M Steinberg; Frances T Hakim; Jeremy J Rose; Zhigang Kang; Yunkai Yu; Liang Cao; Sandra A Mitchell; Annie Im; Steven Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2021-08-25       Impact factor: 5.483

5.  From "being at war" to "getting back on your feet": A qualitative study on experiences of patients with systemic sclerosis treated with hematopoietic stem cell transplantation.

Authors:  Julia Spierings; Carolijn Jm de Bresser; Femke Cc van Rhijn-Brouwer; Arwen Pieterse; Madelon C Vonk; Alexandre E Voskuyl; Jeska K de Vries-Bouwstra; Jacob M van Laar; Marijke C Kars
Journal:  J Scleroderma Relat Disord       Date:  2020-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.